Prostate Cancer Foundation: PCF TACTICAL Awards (Therapy Acceleration To Intercept Cancer Lethality) Targeting Mechanisms of Lethal Prostate Cancer

Request for LOIs for PCF TACTICAL Awards from qualified teams of academic scientists that will specifically address the development of 21st Century therapies for lethal forms of prostate cancer. These awards will be funded depending on the level of innovation in applications received. PCF seeks high-risk, currently unfunded projects from academic institutions around the world. PCF will fund 2-3 of these three-year awards for $5 - $10 Million U.S.D. per award.

https://www.pcf.org/science-impact/for-researchers/open-rfas/

https://res.cloudinary.com/pcf/image/upload/v1651512650/2022_TACTICAL_Award_RFA_5.2.22_co3ajy.pdf